INNODIA Master Protocol for the evaluation of investigational medicinal products in children, adolescents and adults with newly diagnosed type 1 diabetes

BACKGROUND: The INNODIA consortium has established a pan-European infrastructure using validated centres to prospectively evaluate clinical data from individuals with newly diagnosed type 1 diabetes combined with centralised collection of clinical samples to determine rates of decline in beta-cell f...

Descripción completa

Detalles Bibliográficos
Autores principales: Dunger, David B., Bruggraber, Sylvaine F. A., Mander, Adrian P., Marcovecchio, M. Loredana, Tree, Timothy, Chmura, Piotr Jaroslaw, Knip, Mikael, Schulte, Anke M., Mathieu, Chantal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9116021/
https://www.ncbi.nlm.nih.gov/pubmed/35585600
http://dx.doi.org/10.1186/s13063-022-06259-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9116021/
https://www.ncbi.nlm.nih.gov/pubmed/35585600
http://dx.doi.org/10.1186/s13063-022-06259-z

Ejemplares similares